Abstract
Metabolic syndrome (MS) is characterized by several cardiovascular risk factors such as central obesity, hyperglycemia, hypertension, elevated triglycerides and reduced levels of high density lipoprotein (HDL). Rats genetically modified (Zucker obese) have been used as experimental models for obesity, but over time present: insulin resistance, dyslipidemia and hypertension, so these anima…